Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study

Avapritinib treatment improved dermatologic symptoms, decreased skin lesion size, normalized skin lesion color, and reduced skin mast cell burden in patients with ISM.

Authors

Institutions

Publication Details

Journal
Journal of the American Academy of Dermatology
Published
2026-02-01
DOI
https://doi.org/10.1016/j.jaad.2026.02.025
Primary Topic
Mast cells and histamine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study

Johanna Ungerstedt, J. Gotlib, Sonia Cerquozzi, Scott F. Florell et al.
Journal of the American Academy of Dermatology
Mast cells and histamine
article

Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study

Johanna Ungerstedt, J. Gotlib, Sonia Cerquozzi, Scott F. Florell, Ilda Bidollari, Anton Rets, K. Hartmann, Sigurd Broesby‐Olsen, Mariana Castells, Ingunn Dybedal, A Ivan, Hui‐Min Lin, Janet Hong, Mark Rafferty, C. Bulai Livideanu, Vito Sabato, Philippe Schafhausen, Tracy I. George, David A. Wada, Paul van Daele, Cem Akin, Benjamin Lampson, Stéphane Barete, Jens Panse, Deepti H. Radia, Princess U. Ogbogu, Daniel J. DeAngelo, Celalettin Ustun, Frank Siebenhaar, Andreas Reiter, Daniel Shaheen
article en

Abstract

Avapritinib treatment improved dermatologic symptoms, decreased skin lesion size, normalized skin lesion color, and reduced skin mast cell burden in patients with ISM.

Journal of the American Academy of Dermatology
Oslo University Hospital (NO), Brigham and Women's Hospital (US), Rush University Medical Center (US), Harvard University (US), University of Antwerp (BE), Universität Hamburg (DE), University of Calgary (CA), Guy's and St Thomas' NHS Foundation Trust (GB), University of Utah (US), Heidelberg University (DE), University of Michigan (US), Beatson West of Scotland Cancer Centre (GB), Huntsman Cancer Institute (US), Odense University Hospital (DK), Erasmus MC (NL), University Hospital Heidelberg (DE), University Hospital of Basel (CH), Karolinska Institutet (SE), Humboldt-Universität zu Berlin (DE), Sorbonne Université (FR), Düsseldorf University Hospital (DE), Hospital Virgen del Valle (ES), Assistance Publique – Hôpitaux de Paris (FR), Blueprint Medicines (United States) (US), Antwerp University Hospital (BE), University Medical Center Hamburg-Eppendorf (DE), Dana-Farber Cancer Institute (US), Universitätsklinikum Aachen (DE), Pitié-Salpêtrière Hospital (FR), Hôpital Larrey (FR), Rainbow Babies & Children's Hospital (US), Heinrich Heine University Düsseldorf (DE), RWTH Aachen University (DE), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 56%
Mast cells and histamine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.